Dr. Shuo Ma
Claim this profileNorthwestern University
Studies Chronic Lymphocytic Leukemia
Studies Lymphoma
5 reported clinical trials
9 drugs studied
Area of expertise
1Chronic Lymphocytic Leukemia
CD5 positive
CD19 positive
13q positive
2Lymphoma
CD5 positive
CD19 positive
13q positive
Affiliated Hospitals
Clinical Trials Shuo Ma is currently running
JCAR017
for Chronic Leukemia or Lymphoma
This trial tests JCAR017, a therapy using modified immune cells, in adults with hard-to-treat CLL or SLL. It aims to see if these enhanced immune cells can better fight the cancer.
Recruiting1 award Phase 1 & 2
Venetoclax + Obinutuzumab
for Leukemia
This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with the venetoclax and obinutuzumab early (before patients have symptoms) may have better outcomes for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma compared to starting treatment with the venetoclax and obinutuzumab after patients show symptoms.
Recruiting2 awards Phase 31 criteria
More about Shuo Ma
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Shuo Ma has experience with
- Venetoclax
- Ibrutinib
- Obinutuzumab
- Alemtuzumab
- Biopsy
- Ofatumumab
Breakdown of trials Shuo Ma has run
Chronic Lymphocytic Leukemia
Lymphoma
CLL
Leukemia
Chronic B-Cell Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shuo Ma specialize in?
Shuo Ma focuses on Chronic Lymphocytic Leukemia and Lymphoma. In particular, much of their work with Chronic Lymphocytic Leukemia has involved CD5 positive patients, or patients who are CD19 positive.
Is Shuo Ma currently recruiting for clinical trials?
Yes, Shuo Ma is currently recruiting for 2 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Shuo Ma has studied deeply?
Yes, Shuo Ma has studied treatments such as Venetoclax, Ibrutinib, Obinutuzumab.
What is the best way to schedule an appointment with Shuo Ma?
Apply for one of the trials that Shuo Ma is conducting.
What is the office address of Shuo Ma?
The office of Shuo Ma is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.